Simplex Trading
ALZN icon

Simplex Trading’s Alzamend Neuro ALZN Stock Holding History

Simplex Trading’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed -$3K – 9858
2022
Q1 		$3K Sell
2
-16
-89% -$30K ﹤0.01% 9648
2021
Q4 		$46K Buy
+18
New +$55.7K ﹤0.01% 7360

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Simplex Trading's ALZN Position: Q4 2023 in Review

Simplex Trading held its Alzamend Neuro (ALZN) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8695.

Simplex Trading first reported a position in ALZN in Q4 2021 and has held it in 3 quarters since. The position peaked at $125K in Q4 2021. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Simplex Trading held 0 shares of Alzamend Neuro worth $0 as of Q4 2023.
  • Simplex Trading left its Alzamend Neuro share count unchanged in Q4 2023.
  • Alzamend Neuro made up ﹤0.01% of Simplex Trading's portfolio in Q4 2023, its #8695 holding.
  • Simplex Trading first reported a position in Alzamend Neuro in Q4 2021 and has held it in 3 quarters since.
  • Simplex Trading's Alzamend Neuro position peaked at $125K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.